Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix

Gabor Halmos, Andrew V Schally, Jacek Pinski, Manuel Vadillo-Buenfil, Kate Groot

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Antagonists of luteinizing hormone-releasing hormone (LH-RH), unlike the LH-RH agonists, suppress gonadotropins and sex steroid secretion immediately after administration, without initial stimulatory effects. [Ac-D-Nal(2)1,D- Ph(4Cl)2,D-Pal(3)3,D-Cit6,D-Ala10]LH-RH (SB-75; Cetrorelix) is a modern, potent antagonistic analog of LH-RH. In this study, the binding characteristics of receptors for LH-RH in membrane fractions from rat anterior pituitaries were investigated after a single injection of Cetrorelix at a dose of 100 μg per rat. To determine whether the treatment with Cetrorelix can affect the concentration of measurable LH-RH binding sites, we applied an in vitro method to desaturate LH-RH receptors by chaotropic agents such as manganous chloride (MnCl2) and ammonium thiocyanate (NH4SCN). Our results show that the percentages of occupied LH-RH receptors at 1, 3, and 6 h after administration of Cetrorelix were approximately 28%, 14%, and 10%, respectively, of total receptors. At later lime intervals, we could not detect occupied LH-RH binding sites. Ligand competition assays, following in vitro desaturation, demonstrated that rat pituitary LH-RH receptors were significantly (P < 0.01) down-regulated for at least 72 h after administration of Cetrorelix. The lowest receptor concentration was found 3- 6 h after Cetrorelix treatment and a recovery in receptor number began within ≃24 h. The down-regulation of LH-RH binding sites induced by Cetrorelix was accompanied by serum LH and testosterone suppression. Higher LH-RH receptor concentrations coincided with elevated serum hormone levels at later time intervals. Our results indicate that administration of LH-RH antagonist Cetrorelix produces a marked down-regulation of pituitary receptors for LH- RH and not merely an occupancy of binding sites.

Original languageEnglish
Pages (from-to)2398-2402
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume93
Issue number6
DOIs
StatePublished - Mar 19 1996
Externally publishedYes

Fingerprint

Hormone Antagonists
Gonadotropin-Releasing Hormone
Down-Regulation
LHRH Receptors
Binding Sites
Pituitary Hormone-Regulating Hormone Receptors
cetrorelix
Serum
Gonadotropins
Testosterone
Steroids
Hormones
Ligands
Injections

Keywords

  • binding characteristics
  • in vitro desaturation
  • suppression of pituitary-gonadal axis

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix. / Halmos, Gabor; Schally, Andrew V; Pinski, Jacek; Vadillo-Buenfil, Manuel; Groot, Kate.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 93, No. 6, 19.03.1996, p. 2398-2402.

Research output: Contribution to journalArticle

@article{3ec2eb3650684a64b531a965c8f5bde5,
title = "Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix",
abstract = "Antagonists of luteinizing hormone-releasing hormone (LH-RH), unlike the LH-RH agonists, suppress gonadotropins and sex steroid secretion immediately after administration, without initial stimulatory effects. [Ac-D-Nal(2)1,D- Ph(4Cl)2,D-Pal(3)3,D-Cit6,D-Ala10]LH-RH (SB-75; Cetrorelix) is a modern, potent antagonistic analog of LH-RH. In this study, the binding characteristics of receptors for LH-RH in membrane fractions from rat anterior pituitaries were investigated after a single injection of Cetrorelix at a dose of 100 μg per rat. To determine whether the treatment with Cetrorelix can affect the concentration of measurable LH-RH binding sites, we applied an in vitro method to desaturate LH-RH receptors by chaotropic agents such as manganous chloride (MnCl2) and ammonium thiocyanate (NH4SCN). Our results show that the percentages of occupied LH-RH receptors at 1, 3, and 6 h after administration of Cetrorelix were approximately 28{\%}, 14{\%}, and 10{\%}, respectively, of total receptors. At later lime intervals, we could not detect occupied LH-RH binding sites. Ligand competition assays, following in vitro desaturation, demonstrated that rat pituitary LH-RH receptors were significantly (P < 0.01) down-regulated for at least 72 h after administration of Cetrorelix. The lowest receptor concentration was found 3- 6 h after Cetrorelix treatment and a recovery in receptor number began within ≃24 h. The down-regulation of LH-RH binding sites induced by Cetrorelix was accompanied by serum LH and testosterone suppression. Higher LH-RH receptor concentrations coincided with elevated serum hormone levels at later time intervals. Our results indicate that administration of LH-RH antagonist Cetrorelix produces a marked down-regulation of pituitary receptors for LH- RH and not merely an occupancy of binding sites.",
keywords = "binding characteristics, in vitro desaturation, suppression of pituitary-gonadal axis",
author = "Gabor Halmos and Schally, {Andrew V} and Jacek Pinski and Manuel Vadillo-Buenfil and Kate Groot",
year = "1996",
month = "3",
day = "19",
doi = "10.1073/pnas.93.6.2398",
language = "English",
volume = "93",
pages = "2398--2402",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "6",

}

TY - JOUR

T1 - Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix

AU - Halmos, Gabor

AU - Schally, Andrew V

AU - Pinski, Jacek

AU - Vadillo-Buenfil, Manuel

AU - Groot, Kate

PY - 1996/3/19

Y1 - 1996/3/19

N2 - Antagonists of luteinizing hormone-releasing hormone (LH-RH), unlike the LH-RH agonists, suppress gonadotropins and sex steroid secretion immediately after administration, without initial stimulatory effects. [Ac-D-Nal(2)1,D- Ph(4Cl)2,D-Pal(3)3,D-Cit6,D-Ala10]LH-RH (SB-75; Cetrorelix) is a modern, potent antagonistic analog of LH-RH. In this study, the binding characteristics of receptors for LH-RH in membrane fractions from rat anterior pituitaries were investigated after a single injection of Cetrorelix at a dose of 100 μg per rat. To determine whether the treatment with Cetrorelix can affect the concentration of measurable LH-RH binding sites, we applied an in vitro method to desaturate LH-RH receptors by chaotropic agents such as manganous chloride (MnCl2) and ammonium thiocyanate (NH4SCN). Our results show that the percentages of occupied LH-RH receptors at 1, 3, and 6 h after administration of Cetrorelix were approximately 28%, 14%, and 10%, respectively, of total receptors. At later lime intervals, we could not detect occupied LH-RH binding sites. Ligand competition assays, following in vitro desaturation, demonstrated that rat pituitary LH-RH receptors were significantly (P < 0.01) down-regulated for at least 72 h after administration of Cetrorelix. The lowest receptor concentration was found 3- 6 h after Cetrorelix treatment and a recovery in receptor number began within ≃24 h. The down-regulation of LH-RH binding sites induced by Cetrorelix was accompanied by serum LH and testosterone suppression. Higher LH-RH receptor concentrations coincided with elevated serum hormone levels at later time intervals. Our results indicate that administration of LH-RH antagonist Cetrorelix produces a marked down-regulation of pituitary receptors for LH- RH and not merely an occupancy of binding sites.

AB - Antagonists of luteinizing hormone-releasing hormone (LH-RH), unlike the LH-RH agonists, suppress gonadotropins and sex steroid secretion immediately after administration, without initial stimulatory effects. [Ac-D-Nal(2)1,D- Ph(4Cl)2,D-Pal(3)3,D-Cit6,D-Ala10]LH-RH (SB-75; Cetrorelix) is a modern, potent antagonistic analog of LH-RH. In this study, the binding characteristics of receptors for LH-RH in membrane fractions from rat anterior pituitaries were investigated after a single injection of Cetrorelix at a dose of 100 μg per rat. To determine whether the treatment with Cetrorelix can affect the concentration of measurable LH-RH binding sites, we applied an in vitro method to desaturate LH-RH receptors by chaotropic agents such as manganous chloride (MnCl2) and ammonium thiocyanate (NH4SCN). Our results show that the percentages of occupied LH-RH receptors at 1, 3, and 6 h after administration of Cetrorelix were approximately 28%, 14%, and 10%, respectively, of total receptors. At later lime intervals, we could not detect occupied LH-RH binding sites. Ligand competition assays, following in vitro desaturation, demonstrated that rat pituitary LH-RH receptors were significantly (P < 0.01) down-regulated for at least 72 h after administration of Cetrorelix. The lowest receptor concentration was found 3- 6 h after Cetrorelix treatment and a recovery in receptor number began within ≃24 h. The down-regulation of LH-RH binding sites induced by Cetrorelix was accompanied by serum LH and testosterone suppression. Higher LH-RH receptor concentrations coincided with elevated serum hormone levels at later time intervals. Our results indicate that administration of LH-RH antagonist Cetrorelix produces a marked down-regulation of pituitary receptors for LH- RH and not merely an occupancy of binding sites.

KW - binding characteristics

KW - in vitro desaturation

KW - suppression of pituitary-gonadal axis

UR - http://www.scopus.com/inward/record.url?scp=0029865119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029865119&partnerID=8YFLogxK

U2 - 10.1073/pnas.93.6.2398

DO - 10.1073/pnas.93.6.2398

M3 - Article

VL - 93

SP - 2398

EP - 2402

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 6

ER -